[th Dated the 30 FEISHANG ENTERPRISE GROUP CO., LTD. and YANGPU SHUANGHU INDUSTRIAL DEVELOPMENT CO., LIMITED AGREEMENT THE REGISTERED CAPITAL OF BAYANNAOER CITY FEISHANG MINING COMPANY LIMITED 1 THIS AGREEMENT t 30 h BETWEEN: BETWEEN: (1) 飞 尚 实 业 集 团 有 限 公 司 FEISHANG ENTERPRISE GROUP CO., LTD. ( ’ “ ]
[FORM 6-K/A (Amendment No. 1) For the month of December 2017 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x o o o Yes o x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financial results fo]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): December 1, 2017 Cogint, Inc. Delaware 001-37893 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _____________]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 30/11/2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer Huaneng Power International, Inc Date Submitted 01/12/2017 I. Movements in Authorised Share Capital 1. Ordi]
[Item 8.01 Other Events. non-controlling Effective upon the completion of the IPO on November 13, 2017, all of the Sogou shares held by Sohu were redesignated as Class B Ordinary Shares. Each Class B Ordinary Share is entitled to ten votes per share on any matter brought to a vote of Sogou shareholde]
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 30-11-2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer China Petroleum & Chemical Corporation Date Submitted 01/12/2017 I. Movements in Authorised Share Capital 1]
[GU GUOPING 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ý 3. SEC Use Only 4. Source of Funds (See Instructions) AF]
[Biostar Regains Compliance with NASDAQ Continued Listing Requirement XIANYANG, China, December 4, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) (“Biostar” or “the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced t]
